US Stock MarketDetailed Quotes

RDY Dr. Reddy's Laboratories

Watchlist
  • 14.200
  • -0.100-0.70%
Close Dec 4 16:00 ET
  • 14.200
  • 0.0000.00%
Post 16:01 ET
11.83BMarket Cap18.78P/E (TTM)

About Dr. Reddy's Laboratories Company

Dr. Reddy's Laboratories Ltd. engages in the manufacture and marketing of pharmaceutical products. It operates through the following segments: Global Generics, Pharmaceutical Services and Active Ingredients, and Others. The Global Generics segment consists of manufacturing and marketing of prescription and over-the-counter finished pharmaceutical products ready for consumption by the patient, marketed under a brand name or as generic finished dosages with therapeutic equivalence to branded formulations. The Pharmaceutical Services and Active Ingredients segment focuses on manufacturing and marketing of active pharmaceutical ingredients and intermediates, also known as API, which are the principal ingredients for finished pharmaceutical products. The Others segment includes the operations of the subsidiary of the company. The company was founded by Kallam Anji Reddy on February 24, 1984 and is headquartered in Hyderabad, India.

Company Profile

SymbolRDY
Company NameDr. Reddy's Laboratories
Listing DateApr 11, 2001
Issue Price10.04
Founded1984
CEOMr. Erez Israeli
MarketNYSE
Employees27048
Securities TypeDR
ADS Ratio1.0 : 5.0
Fiscal Year Ends03-31
AddressDoor No. 8-2-337,Road No. 3,Banjara Hills
CityHyderabad
ProvinceTelangana
CountryIndia
Zip Code500034
Phone91-40-49002900

Company Executives

  • Name
  • Position
  • Salary
  • Erez Israeli
  • Chief Executive Officer
  • 197.09M
  • Patrick Aghanian
  • Chief Executive Officer, European Generics
  • 63.09M
  • Marc Kikuchi
  • Chief Executive Officer, North America Generics
  • 53.48M
  • M. V. Ramana
  • Chief Executive Officer, Branded Markets, India and Emerging Countries
  • 82.74M
  • Phani Mitra B
  • Chief Information Officer
  • --
  • Parag Agarwal
  • Chief Financial Officer
  • 64.66M
  • B Phanimitra
  • Chief Digital and Information Officer
  • 15.13M
  • M V Narasimham
  • Deputy Chief Financial Officer
  • 48.82M
  • Archana Bhaskar
  • Chief Human Resource Officer
  • 65.21M
  • K. Satish Reddy
  • Co-Chairman of the Board
  • 116.17M
  • G.V. Prasad
  • Co-Chairman of the Board and Managing Director
  • 186.28M
  • Sanjiv Mehta
  • Independent Director
  • 3.32M
  • Dr. Alpna Seth, PhD
  • Independent Director
  • 8.25M
  • Leo Puri
  • Independent Director
  • 17.10M
  • Arun M. Kumar
  • Independent Director
  • 18.77M
  • Penny Wan
  • Independent Director
  • 17.10M
  • Shikha Sanjaya Sharma
  • Independent Director
  • 13.34M
  • Dr. K. P. Krishnan
  • Independent Director
  • 14.18M
  • Dr. Claudio Albrecht
  • Independent Director
  • 16.09M
  • Kalpana Morparia
  • Independent Director
  • 1.67M
  • Krishna Venkatesh
  • Global Head, Quality and Pharmacovigilance
  • 6.15M
  • Sanjay Sharma
  • Global Head of Manufacturing
  • 66.05M
  • Deepak Sapra
  • Global Head of Pharmaceutical Services and Active Ingredients
  • 41.90M
  • Dr. Jayanth Sridhar
  • Global Head of Biologics
  • 34.59M
  • Sushrut Kulkarni
  • Global Head of Integrated Product Development Organisation
  • 55.63M
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries